NYSE:CVS - CVS Health Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$71.88 -1.49 (-2.03 %)
(As of 12/14/2018 04:00 PM ET)
Previous Close$71.88
Today's Range$71.61 - $73.44
52-Week Range$60.14 - $83.88
Volume10.62 million shs
Average Volume10.15 million shs
Market Capitalization$74.75 billion
P/E Ratio12.18
Dividend Yield2.73%
Beta0.98
CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, Medicare Part D plans, managed Medicaid plans, plans offered on public and private exchanges, other sponsors of health benefit plans, and individuals under the CVS Caremark Pharmacy Services, Caremark, CVS Specialty, AccordantCare, SilverScript, Wellpartner, NovoLogix, Coram, Navarro Health Services, and ACS Pharmacy names. As of December 31, 2017, it had 23 retail specialty pharmacy stores, 18 specialty mail order pharmacies and 4 mail order dispensing pharmacies, and 83 branches for infusion and enteral services. The Retail/LTC segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as offers photo finishing services. It has 9,803 retail stores in 49 states, the District of Columbia, Puerto Rico, and Brazil primarily under the CVS Pharmacy, CVS, CVS Pharmacy y más, Longs Drugs, Navarro Discount Pharmacy, and Drogaria Onofre names; online retail pharmacy Websites; and 37 onsite pharmacy stores, long-term care pharmacy operations, and retail health care clinics. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

Receive CVS News and Ratings via Email

Sign-up to receive the latest news and ratings for CVS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Drug stores & proprietary stores
Sub-IndustryDrug Retail
SectorRetail/Wholesale
Current SymbolNYSE:CVS
Previous Symbol
CUSIP12665010
Phone401-765-1500

Debt

Debt-to-Equity Ratio1.66
Current Ratio2.44
Quick Ratio1.94

Price-To-Earnings

Trailing P/E Ratio12.18
Forward P/E Ratio10.24
P/E Growth0.96

Sales & Book Value

Annual Sales$184.77 billion
Price / Sales0.40
Cash Flow$8.4169 per share
Price / Cash Flow8.54
Book Value$37.21 per share
Price / Book1.93

Profitability

EPS (Most Recent Fiscal Year)$5.90
Net Income$6.62 billion
Net Margins1.65%
Return on Equity18.69%
Return on Assets5.61%

Miscellaneous

Employees246,000
Outstanding Shares1,018,800,000
Market Cap$74.75 billion
OptionableOptionable

CVS Health (NYSE:CVS) Frequently Asked Questions

What is CVS Health's stock symbol?

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

How often does CVS Health pay dividends? What is the dividend yield for CVS Health?

CVS Health announced a quarterly dividend on Thursday, October 4th. Shareholders of record on Wednesday, October 24th will be given a dividend of $0.50 per share on Thursday, November 1st. This represents a $2.00 dividend on an annualized basis and a yield of 2.78%. The ex-dividend date is Tuesday, October 23rd. View CVS Health's Dividend History.

How were CVS Health's earnings last quarter?

CVS Health Corp (NYSE:CVS) posted its quarterly earnings data on Tuesday, November, 6th. The pharmacy operator reported $1.73 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $1.71 by $0.02. The pharmacy operator had revenue of $47.27 billion for the quarter, compared to analyst estimates of $47.22 billion. CVS Health had a return on equity of 18.69% and a net margin of 1.65%. The firm's revenue was up 2.4% on a year-over-year basis. During the same period in the previous year, the firm earned $1.50 EPS. View CVS Health's Earnings History.

When is CVS Health's next earnings date?

CVS Health is scheduled to release their next quarterly earnings announcement on Thursday, February 14th 2019. View Earnings Estimates for CVS Health.

How can I listen to CVS Health's earnings call?

CVS Health will be holding an earnings conference call on Wednesday, February 20th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

What guidance has CVS Health issued on next quarter's earnings?

CVS Health issued an update on its FY18 earnings guidance on Tuesday, November, 6th. The company provided EPS guidance of $6.98-7.08 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $7.04. CVS Health also updated its FY 2018 guidance to $6.98-7.08 EPS.

What price target have analysts set for CVS?

19 brokers have issued 12 month price objectives for CVS Health's shares. Their forecasts range from $77.84 to $104.00. On average, they expect CVS Health's share price to reach $91.52 in the next twelve months. This suggests a possible upside of 27.3% from the stock's current price. View Analyst Price Targets for CVS Health.

What is the consensus analysts' recommendation for CVS Health?

19 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 3 hold ratings, 14 buy ratings and 2 strong buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CVS Health.

Has CVS Health been receiving favorable news coverage?

News stories about CVS stock have been trending somewhat positive recently, according to InfoTrie Sentiment. The research firm rates the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. CVS Health earned a news sentiment score of 1.2 on InfoTrie's scale. They also gave press coverage about the pharmacy operator a news buzz of 6.0 out of 10, meaning that recent news coverage is somewhat likely to have an effect on the stock's share price in the next several days.

Are investors shorting CVS Health?

CVS Health saw a decrease in short interest during the month of November. As of November 30th, there was short interest totalling 35,182,217 shares, a decrease of 41.2% from the November 15th total of 59,852,649 shares. Based on an average daily trading volume, of 10,480,873 shares, the days-to-cover ratio is presently 3.4 days. Currently, 2.7% of the company's shares are short sold. View CVS Health's Current Options Chain.

Who are some of CVS Health's key competitors?

Who are CVS Health's key executives?

CVS Health's management team includes the folowing people:
  • Mr. Larry J. Merlo, CEO & Director (Age 62)
  • Mr. David M. Denton, Exec. VP & CFO (Age 53)
  • Mr. Jonathan C. Roberts, Exec. VP & COO (Age 62)
  • Mr. Thomas Michael Moriarty, Exec. VP, Chief of Policy & External Affairs Officer and Gen. Counsel (Age 54)
  • Ms. Eva C. Boratto, Exec. VP, Controller & Chief Accounting Officer (Age 51)

Who are CVS Health's major shareholders?

CVS Health's stock is owned by a number of of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (8.33%), Vanguard Group Inc (8.33%), BlackRock Inc. (7.48%), FMR LLC (2.95%), Dodge & Cox (1.48%) and Dodge & Cox (1.48%). Company insiders that own CVS Health stock include Andrew Sussman, C David Brown II, David M Denton, Eva C Boratto, Helena Foulkes, Jonathan C Roberts, Kevin Hourican, Larry J Merlo, Lisa Bisaccia, Richard J Swift, Thomas M Moriarty and Troyen A Brennan. View Institutional Ownership Trends for CVS Health.

Which institutional investors are selling CVS Health stock?

CVS stock was sold by a variety of institutional investors in the last quarter, including Capital Research Global Investors, The Manufacturers Life Insurance Company, Mitsubishi UFJ Trust & Banking Corp, State Treasurer State of Michigan, Swedbank, PGGM Investments, Clearbridge Investments LLC and Bridgewater Associates LP. Company insiders that have sold CVS Health company stock in the last year include David M Denton, Eva C Boratto, Helena Foulkes, Kevin Hourican, Lisa Bisaccia and Troyen A Brennan. View Insider Buying and Selling for CVS Health.

Which institutional investors are buying CVS Health stock?

CVS stock was acquired by a variety of institutional investors in the last quarter, including Dodge & Cox, Dodge & Cox, Capital International Investors, Diamond Hill Capital Management Inc., BlackRock Inc., Vanguard Group Inc, Vanguard Group Inc. and Senator Investment Group LP. View Insider Buying and Selling for CVS Health.

How do I buy shares of CVS Health?

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is CVS Health's stock price today?

One share of CVS stock can currently be purchased for approximately $71.88.

How big of a company is CVS Health?

CVS Health has a market capitalization of $74.75 billion and generates $184.77 billion in revenue each year. The pharmacy operator earns $6.62 billion in net income (profit) each year or $5.90 on an earnings per share basis. CVS Health employs 246,000 workers across the globe.

What is CVS Health's official website?

The official website for CVS Health is http://www.cvshealth.com.

How can I contact CVS Health?

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]


MarketBeat Community Rating for CVS Health (NYSE CVS)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  1,049 (Vote Outperform)
Underperform Votes:  563 (Vote Underperform)
Total Votes:  1,612
MarketBeat's community ratings are surveys of what our community members think about CVS Health and other stocks. Vote "Outperform" if you believe CVS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CVS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/15/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel